IPS Plus Abstinence-Contingent Wage Supplement for Substance Use Disorder

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Center for Learning and Health, Baltimore, MDSubstance Use DisorderIPS Plus Abstinence-Contingent Wage Supplement - Behavioral
Eligibility
18 - 55
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test a new way to help people with addiction stay abstinent and employed. The intervention will combine a therapeutic workplace, supported employment, and abstinence-contingent wage supplements.

Eligible Conditions
  • Substance Use Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Standard outpatient treatment plus Laddr®
1
W-SUDs
1
Guanfacine

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 1 year

1 year
Alcohol Abstinence
Employment

Trial Safety

Safety Progress

1 of 3

Similar Trials

2
Standard outpatient treatment plus Laddr®
2
W-SUDs
2
Guanfacine

Trial Design

2 Treatment Groups

Usual Care Control
1 of 2
IPS Plus Abstinence-Contingent Wage Supplement
1 of 2

Active Control

Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: IPS Plus Abstinence-Contingent Wage Supplement · No Placebo Group · N/A

IPS Plus Abstinence-Contingent Wage Supplement
Behavioral
Experimental Group · 1 Intervention: IPS Plus Abstinence-Contingent Wage Supplement · Intervention Types: Behavioral
Usual Care ControlNoIntervention Group · 1 Intervention: Usual Care Control · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,092 Previous Clinical Trials
31,769,200 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
729 Previous Clinical Trials
1,338,193 Total Patients Enrolled
Kenneth Silverman, Ph.D.Principal InvestigatorJohns Hopkins University
10 Previous Clinical Trials
969 Total Patients Enrolled
August F. Holtyn, Ph.D.Principal InvestigatorJohns Hopkins University

Eligibility Criteria

Age 18 - 55 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a substance addiction that meets the criteria outlined in the DSM-V.
References

Frequently Asked Questions

Is the cutoff age for participation in this trial beyond 45 years?

"This clinical trial is only open for those aged between 18 and 55. However, there are separate studies available for minors (76) and seniors (255)." - Anonymous Online Contributor

Unverified Answer

To what extent is this study being embraced by participants?

"Affirmative. Clinicaltrials.gov data demonstrates that recruiting for this medical trial is on-going, having first been posted on January 2nd 2019 and recently updated as of May 6th 2022. 100 participants must be enrolled from a single clinical centre." - Anonymous Online Contributor

Unverified Answer

For what category of patients is this trial most suitable?

"Patients that hope to be accepted into this clinical trial must have a history of drug abuse and fit into the age range of 18-55. The study is seeking around 100 volunteers in total." - Anonymous Online Contributor

Unverified Answer

Are there any enrolment opportunities available for this trial at the moment?

"Affirmative. Clinicaltrials.gov demonstrates that this medical research, which was initially posted on January 2nd 2019, is actively seeking participants. Approximately 100 volunteers must be recruited from 1 clinical center." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top